TrialJAMA2026

Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.

Jamie E Chaft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.